Serving as More Than a Partner to Support a Combination Antibiotic Clinical Trial

A large pharmaceutical company was running a complex antibiotic study for a treatment targeting complicated intra-abdominal infection (cIAI). Based on extensive experience with facilitating and executing these complex antibiotic studies, Labcorp Drug Development was selected to support this Phase IIb trial. This case study highlights the team's approach to remove barriers to enrollment and keep the study on schedule.

Filed In

Clinical Trials
Infectious Disease
Labs & Centralized Testing
Stage (Late, PhIIb-III)